AMZN
207.08
-1.46%↓
TSLA
382.42
+0.43%↑
HD
330.59
-0.06%↓
TM
209.02
-0.58%↓
MCD
307.93
-0.08%↓
AMZN
207.08
-1.46%↓
TSLA
382.42
+0.43%↑
HD
330.59
-0.06%↓
TM
209.02
-0.58%↓
MCD
307.93
-0.08%↓
AMZN
207.08
-1.46%↓
TSLA
382.42
+0.43%↑
HD
330.59
-0.06%↓
TM
209.02
-0.58%↓
MCD
307.93
-0.08%↓
AMZN
207.08
-1.46%↓
TSLA
382.42
+0.43%↑
HD
330.59
-0.06%↓
TM
209.02
-0.58%↓
MCD
307.93
-0.08%↓
AMZN
207.08
-1.46%↓
TSLA
382.42
+0.43%↑
HD
330.59
-0.06%↓
TM
209.02
-0.58%↓
MCD
307.93
-0.08%↓
24h
Praegune
Min
5.21
Max
5.45
Sissetulek | 8.1M -44M |
|---|---|
Müük | 3.6M 109M |
Aktsiakasum | -0.55 |
Kasumimarginaal | -40.631 |
Töötajad | 1,395 |
EBITDA | -14M -50M |
Soovitused | Neutraalne |
|---|---|
12 kuu keskmine prognoos | +17.4% upside |
Järgmine tulemuste avaldamine | 3. juuni 2026 |
|---|
Turukapital | -24M 128M |
|---|---|
Eelmine avamishind | 6.03 |
Eelmine sulgemishind | 5.28 |
By Trading Central
Kindlus
Strong Bearish Evidence
0.58 / 0.6165 Toetus ja vastupanu
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
23. märts 2026, 23:47 UTC
Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update
DJ
Loe
23. märts 2026, 22:55 UTC
Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion
DJ
Loe
23. märts 2026, 21:51 UTC
Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update
DJ
Loe
23. märts 2026, 23:59 UTC
Global Equities Roundup: Market Talk
DJ
Loe
23. märts 2026, 23:59 UTC
Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk
DJ
Loe
23. märts 2026, 23:50 UTC
Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk
DJ
Loe
23. märts 2026, 23:37 UTC
Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk
DJ
Loe
23. märts 2026, 22:42 UTC
Global Equities Roundup: Market Talk
DJ
Loe
23. märts 2026, 22:42 UTC
Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk
DJ
Loe
23. märts 2026, 22:40 UTC
Gilead Sciences to Buy Ouro Medicines for Up to $2.18B
DJ
Loe
23. märts 2026, 22:23 UTC
Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk
DJ
Loe
23. märts 2026, 22:22 UTC
Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease
DJ
Loe
23. märts 2026, 22:21 UTC
Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales
DJ
Loe
23. märts 2026, 22:21 UTC
Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China
DJ
Loe
23. märts 2026, 22:20 UTC
Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD
DJ
Loe
23. märts 2026, 22:20 UTC
Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD
DJ
Loe
23. märts 2026, 22:19 UTC
Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders
DJ
Loe
23. märts 2026, 22:19 UTC
Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets
DJ
Loe
23. märts 2026, 22:18 UTC
Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD
DJ
Loe
23. märts 2026, 22:15 UTC
Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD
DJ
Loe
23. märts 2026, 22:08 UTC
Ebos Needs to Reset Its Gearing Targets -- Market Talk
DJ
Loe
23. märts 2026, 21:42 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Loe
23. märts 2026, 21:42 UTC
RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk
DJ
Loe
23. märts 2026, 21:32 UTC
WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK
DJ
Loe
23. märts 2026, 21:32 UTC
WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK
DJ
Loe
23. märts 2026, 21:32 UTC
WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK
DJ
Loe
23. märts 2026, 21:10 UTC
Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com
DJ
Loe
23. märts 2026, 20:50 UTC
Tech, Media & Telecom Roundup: Market Talk
DJ
Loe
23. märts 2026, 20:50 UTC
Health Care Roundup: Market Talk
DJ
Loe
23. märts 2026, 20:50 UTC
Basic Materials Roundup: Market Talk
DJ
Loe
Hinnamuutus
By TipRanks
12 kuu keskmine prognoos
Keskmine 6.14 USD 17.4%
Kõrge 7 USD
Madal 5 USD
Põhineb 8 Wall Streeti analüütiku instrumendi ChargePoint Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.
By TipRanks
Neutraalne
8 ratings
0
Osta
6
Hoia
2
Müü
Põhineb 8 analüütiku instrumendi ChargePoint Holdings Inc aktsia reitingul - viimase 3 kuu andmed.
By Trading Central
Lühikene perspektiiv
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Keskpikk perspektiiv
Strong Bullish Evidence
Recent bullish events outweigh bearish events.
Pikk perspektiiv
Weak Bearish Evidence
All events are bearish.
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$